204 related articles for article (PubMed ID: 19289498)
1. Regulation of p53 by TopBP1: a potential mechanism for p53 inactivation in cancer.
Liu K; Bellam N; Lin HY; Wang B; Stockard CR; Grizzle WE; Lin WC
Mol Cell Biol; 2009 May; 29(10):2673-93. PubMed ID: 19289498
[TBL] [Abstract][Full Text] [Related]
2. TopBP1 mediates mutant p53 gain of function through NF-Y and p63/p73.
Liu K; Ling S; Lin WC
Mol Cell Biol; 2011 Nov; 31(22):4464-81. PubMed ID: 21930790
[TBL] [Abstract][Full Text] [Related]
3. Mutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin.
Liu K; Lin FT; Graves JD; Lee YJ; Lin WC
Proc Natl Acad Sci U S A; 2017 May; 114(19):E3766-E3775. PubMed ID: 28439015
[TBL] [Abstract][Full Text] [Related]
4. Expression of TopBP1 in hereditary breast cancer.
Forma E; Krzeslak A; Bernaciak M; Romanowicz-Makowska H; Brys M
Mol Biol Rep; 2012 Jul; 39(7):7795-804. PubMed ID: 22544570
[TBL] [Abstract][Full Text] [Related]
5. TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival.
Liu K; Luo Y; Lin FT; Lin WC
Genes Dev; 2004 Mar; 18(6):673-86. PubMed ID: 15075294
[TBL] [Abstract][Full Text] [Related]
6. TopBP1 deficiency causes an early embryonic lethality and induces cellular senescence in primary cells.
Jeon Y; Ko E; Lee KY; Ko MJ; Park SY; Kang J; Jeon CH; Lee H; Hwang DS
J Biol Chem; 2011 Feb; 286(7):5414-22. PubMed ID: 21149450
[TBL] [Abstract][Full Text] [Related]
7. TopBP1 promotes malignant progression and correlates with poor prognosis in osteosarcoma.
Wu DP; Yan XB; Liu LG; Tian C; Han K; Zhang H; Min DL
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4022-4031. PubMed ID: 29028101
[TBL] [Abstract][Full Text] [Related]
8. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR.
Winter M; Sombroek D; Dauth I; Moehlenbrink J; Scheuermann K; Crone J; Hofmann TG
Nat Cell Biol; 2008 Jul; 10(7):812-24. PubMed ID: 18536714
[TBL] [Abstract][Full Text] [Related]
9. Association between the c.*229C>T polymorphism of the topoisomerase IIβ binding protein 1 (TopBP1) gene and breast cancer.
Forma E; Brzeziańska E; Krześlak A; Chwatko G; Jóźwiak P; Szymczyk A; Smolarz B; Romanowicz-Makowska H; Różański W; Bryś M
Mol Biol Rep; 2013 May; 40(5):3493-502. PubMed ID: 23277395
[TBL] [Abstract][Full Text] [Related]
10. TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53.
Lv Y; Huo Y; Yu X; Liu R; Zhang S; Zheng X; Zhang X
Drug Des Devel Ther; 2016; 10():3053-3064. PubMed ID: 27729767
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor-induced tumor suppressor, KLLN, inhibits breast cancer growth and transcriptionally activates p53/p73-mediated apoptosis in breast carcinomas.
Wang Y; He X; Yu Q; Eng C
Hum Mol Genet; 2013 Jun; 22(11):2263-72. PubMed ID: 23418309
[TBL] [Abstract][Full Text] [Related]
12. A small-molecule inhibitor of TopBP1 exerts anti-MYC activity and synergy with PARP inhibitors.
Lin FT; Liu K; Garan LAW; Folly-Kossi H; Song Y; Lin SJ; Lin WC
Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2307793120. PubMed ID: 37878724
[TBL] [Abstract][Full Text] [Related]
13. Regulation of E2F1 by BRCT domain-containing protein TopBP1.
Liu K; Lin FT; Ruppert JM; Lin WC
Mol Cell Biol; 2003 May; 23(9):3287-304. PubMed ID: 12697828
[TBL] [Abstract][Full Text] [Related]
14. Calcein-acetoxymethy ester enhances the antitumor effects of doxorubicin in nonsmall cell lung cancer by regulating the TopBP1/p53RR pathway.
Lv Y; Liu R; Xie S; Zheng X; Mao J; Cai Y; Chen W
Anticancer Drugs; 2017 Sep; 28(8):861-868. PubMed ID: 28628491
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERalpha and p53.
Morris JS; Nixon C; Bruck A; Nasir L; Morgan IM; Philbey AW
Vet J; 2008 Feb; 175(2):218-26. PubMed ID: 17336111
[TBL] [Abstract][Full Text] [Related]
16. Proteomic identification of PSF and p54(nrb) as TopBP1-interacting proteins.
Kuhnert A; Schmidt U; Monajembashi S; Franke C; Schlott B; Grosse F; Greulich KO; Saluz HP; Hänel F
J Cell Biochem; 2012 May; 113(5):1744-53. PubMed ID: 22213094
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer.
Liu K; Graves JD; Lin FT; Lin WC
J Biol Chem; 2021; 296():100382. PubMed ID: 33556369
[TBL] [Abstract][Full Text] [Related]
18. TopBP1: A BRCT-scaffold protein functioning in multiple cellular pathways.
Wardlaw CP; Carr AM; Oliver AW
DNA Repair (Amst); 2014 Oct; 22():165-74. PubMed ID: 25087188
[TBL] [Abstract][Full Text] [Related]
19. A DNA damage-regulated BRCT-containing protein, TopBP1, is required for cell survival.
Yamane K; Wu X; Chen J
Mol Cell Biol; 2002 Jan; 22(2):555-66. PubMed ID: 11756551
[TBL] [Abstract][Full Text] [Related]
20. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
Kim EJ; Park JS; Um SJ
Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
